Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Saturday, April 4, 2026

Micro/Nanoparticles in the Nose-Brain Axis: Implications for Pathogenesis and Therapeutic Interventions

 Your competent? doctor is already aware of the nose to brain axis and diligently working on solutions for survivor recovery, right? OH NO! Knows nothing AND does nothing! You really picked the worst of the lot. And your board of directors is so incompetent they can't recognize incompetence in their hospital!

Micro/Nanoparticles in the Nose-Brain Axis: Implications for Pathogenesis and Therapeutic Interventions

 Authors:  Mou YK, Wang Y, Wang HR , Cheng YC, Shen H, Ren C Song XC 
Received 28 November 2025 
Accepted for publication 16 March 2026
Published 3 April 2026 
Volume 2026:21 585021 
DOI https://doi.org/10.2147/IJN.S585021 
Checked for plagiarism;Yes 

Peer reviewer comments 4

Editor who approved publication: Dr Sachin Mali



Ya-Kui Mou,1– 4,* Quan Li,2,5,* Yao Wang,1– 4,* Xiao-Yu Song,1– 4 Han-Rui Wang,1– 4 Wan-Chen Liu,1– 4 Yuan-Chao Cheng,1– 4 Hui Shen,1– 4 Chao Ren,2,6,7 Xi-Cheng Song1– 4

1Department of Otorhinolaryngology, Head and Neck Surgery, Yantai Yuhuangding Hospital, Qingdao University, Yantai, People’s Republic of China; 2Shandong Provincial Key Laboratory of Neuroimmune Interaction and Regulation, Yantai Yuhuangding Hospital, Yantai, People’s Republic of China; 3Shandong Provincial Clinical Research Center for Otorhinolaryngologic Diseases, Yantai Yuhuangding Hospital, Yantai, People’s Republic of China; 4Yantai Key Laboratory of Otorhinolaryngologic Diseases, Yantai Yuhuangding Hospital, Qingdao University, Yantai, People’s Republic of China; 5Department of Emergency, Yantai Yuhuangding Hospital, Qingdao University, Yantai, People’s Republic of China; 6Department of Neurology, Yantai Yuhuangding Hospital, Qingdao University, Yantai, People’s Republic of China; 7Yantai Municipal Key Medical and Health Laboratory of Yantai Yuhuangding Hospital (Interdisciplinary Brain Science and Geriatric Health Laboratory), Qingdao University, Yantai, People’s Republic of China

*These authors contributed equally to this work

Correspondence: Chao Ren, Department of Neurology. Yantai Yuhuangding Hospital, Qingdao University, No. 20, East Road, Zhifu District, Yantai, 264000, People’s Republic of China, Tel +86535 6691999, Fax +86535 6240341, Email renchaotg@126.com Xi-Cheng Song, Department of Otolaryngology, Head and Neck Surgery. Yantai Yuhuangding Hospital, Qingdao University, No. 20, East Road, Zhifu District, Yantai, 264000, People’s Republic of China, Tel +86535 6691999, Fax +86535 6240341, Email drxchsong@163.com

Abstract: The nose-brain axis (NBA) is a crucial bidirectional deliverypathway between the nasal cavity and the central nervous system (CNS) that influences both neurophysiology and disease progression. In addition to serving as a route for drug delivery, the NBA plays an active role in neurological disorders by mediating inflammatory responses, microbial interactions, and environmental exposure. Emerging evidence suggests that the NBA may be mechanistically relevant to CNS disorders, particularly within neurodegeneration frameworks such as the Braak and dual-hit hypotheses, which emphasize early olfactory or other peripheral involvements. This review explores how micro/nanoparticles interact with the NBA, not only as therapeutic carriers but also as factors contributing to neuroinflammation and neurodegeneration. Pathogenic micro/nanoparticles, including environmental pollutants and industrial nanoparticles, have been implicated in the exacerbation of CNS disorders by triggering oxidative stress and immune activation in both nasal and brain tissues. Conversely, therapeutic micro/nanoparticles such as biomimetic, synthetic, and cell-derived formulations represent promising strategies for modulating neuroinflammation, enhancing neuroprotection, and restoring CNS function through nasal-targeted interventions. However, substantial gaps remain in the existing understanding of the influences of nasal immune responses, microbiota, and barrier integrity on CNS health through the NBA. Addressing these challenges is critical for leveraging micro-/nanoparticles for the prevention and treatment of CNS diseases.

No comments:

Post a Comment